---
title: "CJEU, C-673/18: no supplementary protection certificate for a new therapeutic application of an active ingredient which has already been the subject of a previous marketing authorisation"
description: The Court of Justice ruled that a second Supplementary Protection Certificate (SPC) cannot be granted, in case of a drug whose active ingredients are already covered by a previous marketing authorisation (MA), no matter if the (second) MA concerns a new therapeutic indication.
---

[News & Publications ](https://www.jacobacci-law.com/news-and-publications)

# [CJEU, C-673/18: no supplementary protection certificate for a new therapeutic application of an active ingredient which has already been the subject of a previous marketing authorisation](https://www.jacobacci-law.com/news-and-publications/cjeu-c-673-18-no-supplementary-protection-certificate-for-a-new-therapeutic-application-of-an-active-ingredient)

 Written by [Studio Legale Jacobacci & Associati](https://www.jacobacci-law.com/news-and-publications/author/studio-legale-jacobacci-&-associati) | July 29, 2020

The Court of Justice ruled that a second Supplementary Protection Certificate (SPC) cannot be granted, in case of a drug whose active ingredients are already covered by a previous marketing authorisation (MA), no matter if the (second) MA concerns a new therapeutic indication.

[DOWNLOAD PDF](https://www.jacobacci-law.com/hubfs/News/C-673%2018%20SPCs.pdf?hsLang=en)

[View full post](https://www.jacobacci-law.com/news-and-publications/cjeu-c-673-18-no-supplementary-protection-certificate-for-a-new-therapeutic-application-of-an-active-ingredient)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Studio Legale Jacobacci & Associati"
  },
  "dateModified" : "2024-01-23T15:23:37.093Z",
  "datePublished" : "2020-07-29T15:52:00Z",
  "headline" : "CJEU, C-673/18: no supplementary protection certificate for a new therapeutic application of an active ingredient which has already been the subject of a previous marketing authorisation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 800,
    "url" : "https://8649241.fs1.hubspotusercontent-na1.net/hubfs/8649241/news-featured.jpg",
    "width" : 1200
  },
  "mainEntityOfPage" : "https://www.jacobacci-law.com/news-and-publications/cjeu-c-673-18-no-supplementary-protection-certificate-for-a-new-therapeutic-application-of-an-active-ingredient",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 0.0,
      "url" : "https://www.jacobacci-law.com/hubfs/Logos/Studio-Legale-Jacobacci-Associati-logo-2023-color.svg",
      "width" : 0.0
    },
    "name" : "News & Publications"
  }
}
```